Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.07T, Eli Lilly(LLY) trades at $1,132.00. The stock has a price-to-earnings ratio of 41.20 and currently yields dividends of 56.4%.
On 2026-06-10, Eli Lilly(LLY) stock moved within a range of $1,130.00 to $1,166.42. With shares now at $1,132.00, the stock is trading +0.2% above its intraday low and -3.0% below the session's peak.
Trading activity shows a volume of 2.69M, compared to an average daily volume of 3.61M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Co. has begun a Phase 3 trial called “A Study of Brenipatide in...
...
Eli Lilly (LLY) and Company announced that the U.S. FDA approved a regimen of one maintenance dose every eight weeks of a single injection of Ebglyss for subcut...
Analyst ratings
85%
of 33 ratingsMore LLY News
Eli Lilly (NYSE:LLY) is moving into vaccines and infectious diseases with three acquisitions, reportedly totaling nearly $4 billion for Curevo, LimmaTech Biolog...
Swedish biotech AlzeCure Pharma announced on Tuesday a collaboration and a licensing agreement with Eli Lilly (LLY) to develop an Alzheimer’s therapy as part of...
Key Points Investors are excited about retatrutide's potential. Rival drugmakers are finding it difficult to keep pace with the healthcare leader. 10 stocks...
Key Points Prevention could become Eli Lilly's next multibillion-dollar growth driver. Antibiotic resistance is increasing demand for preventive vaccine solut...
Key Points Zealand Pharma reported a high drop-out rate in a phase III trial of Survodutide, due to undesirable side effects experienced by patients. That's g...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. This Phase 1 study, officially titled “A Phase 1, Open-label Study of the Abso...
Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support 6/06/2026 Eli Lilly leads three health care stocks to watch as the market appears to be rot...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.